Skip to main content

Currently Skimming:

Appendix C: Statement of Task
Pages 105-106

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 105...
... Because regenerative engineered therapies rely on live cells and/or scaffolds, there are inherent challenges in quality control associated with variability in source and final products. Each patient recipient, tissue donor, and product application is unique and therefore the field faces complexities in the development of safe and effective new products and therapies that are not faced by developers of more conventional therapies.
From page 106...
... 106 EXPLORING VARIABILITY IN REGENERATIVE ENGINEERING PRODUCTS The ad hoc committee will develop the workshop agenda, select and invite speakers and discussants, and may moderate the discussions. Proceedings of the workshop will be prepared by a designated rapporteur in accordance with institutional policy and procedures.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.